Christina Poh, Francisco Hernandez-Ilizaliturri, Marek Trneny, Julie Wu, Philomena Colucci, Oscar Bortolami, Laurie Sehn. "Phase 3 study (inMIND) of tafasitamab plus lenalidomide and rituximab for relapsed or refractory follicular lymphoma: Clinical characteristics and outcomes by age." Blood, 2025. doi:10.1182/blood-2025-3582